60 Degrees Pharmaceuticals, LLC (60P) announced that initial testing in cell culture shows that ARAKODA (tafenoquine) is active against SARS-CoV-2 at clinically relevant concentrations.
GlaxoSmithKline is reportedly considering whether to split its business into a consumer health spin-off and standalone pharmaceutical and vaccines group.